The corona virus epidemic disrupted people’s lives. Do not know how many people became unemployed all over the world, and how many people lost their means of earning. The vaccine is awaited to get rid of this disease.
At the same time, the US-based Moderna Company expects interim results of its Kovid vaccine trials next month. The company’s chief executive says the US government may approve emergency use of the vaccine in December if the vaccine produces positive results.
Moderna CEO Bansell said that the US government has spent billions of dollars for vaccines and treatment. While the study started on 30,000 people in the US to test the vaccine in July, the first analysis is likely in November, but it is difficult to predict exactly that week. Let me tell you that Moderna has been successful in its first phase of the company’s Kovid-19 vaccine trial. Results have shown that this drug is increasing immunity in patients. According to US researchers, this trial is being done on 45 healthy volunteers in the first phase.
Antibodies that kill the virus have been found in high amounts among those who were given two doses of the vaccine as a trial. According to research published in the New England Journal, these patients recovering from Kovid-19 have, on average, more antibodies.